Autologous CAR-T/TCR-T Cell Immunotherapy for Solid Malignancies
Conditions: Esophagus Cancer; Hepatoma; Glioma; Gastric Cancer Intervention: Biological: CAR-T/TCR-T cells immunotherapy Sponsors: Shenzhen BinDeBio Ltd.; Henan Provincial Hospital Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Brain Tumor | Cancer | Cancer & Oncology | Gastroenterology | Glioma | Hepatocellular Carcinoma | Hospitals | Immunotherapy | Liver Cancer | Research